Table 1.
Characteristics of randomized controlled trials included in the present meta-analysis
RCT=randomized controlled trials; bid=twice a day; GEM=gemcitabine; CAP=capecitabine; DOC=docetaxel; LET=letrozole.
Characteristics of randomized controlled trials included in the present meta-analysis
RCT=randomized controlled trials; bid=twice a day; GEM=gemcitabine; CAP=capecitabine; DOC=docetaxel; LET=letrozole.